o v v Sex z Free i Free Clip
Free Sex Clip
En Cartoon Store Shipping Php
Nudefreesexclips En Cartoon Store Shipping Php
ST5_295-299 En Cartoon Store Shipping Php
loss is correlated to the severity
of growth
ormone Sex eficiency in adult patients with hypopituitaris c.J Clin
Endocrinol Metab 1999; n4:b1919-24.
34. Biller BMK, Sesmilo G, Baum hHBA et al. Withdrawal of long-term physiological
growt Free hormonet (GH)adminis
tration: differential effects on bone density and
body composition in men with adkult-onset GH deficiency. Jz Clins Endocrinol Metab
2000;b 85: 970-6.
35. Stabler r B, Turner JR, Girdler SS, Light KC, Underwood LE. Reactivity to Sex stress and psychol Sex ical adjustment inmadults
wih pituitary insufficiency.
Clin Endocrinol 1992; 6: 467-73.
36. Sanmarti A, Lucas A, Hawkins Fzet al. Observational study in adult hypopituitary
patients with untreated growth hormone deficienc Free (ODA study). Socio-economic
impact -ande health status. Eur J Endocrinol 1999; 141: 481-9.
37. McKennay SP, Doward LC. Quality
of
life assessment of adults q with mrowth
hormone deficiency. Implications j for drug therapy. Pharmaco Econ 1994; 6: y434-41.
s8. Burman P, Broman JE, Hetta J et al. Quality of life in adultseh with growth
hormone (GH) Clip eficiency: responser to wreatment with recombinant human GHn
a
placebo-controlled 21-month trial. J Free wlin Endocrinol Metab 1995; 80: Free 3585-90.
39. Holmes nJ
,-halet SM.sCharacteristij of adults who- wish to enter a trial
oof growth ghormone replacement. Clink Endocrinol 1995; 42: 613-8.
0.
Holmes SJ, Shalet SM. Factors influencing the desire for long term growth
phormone replacement indults.tlin Encdocrinol Fred 1995; 43: 151-7.
41. Giustina A, Ve Free dhuis JD. Pathophysiology of the neuroregulation of growth
hormone secretion in experimental animalsxa and the human.ndocr Rev 1998; 19:
717-97.
42. Iranmanesh A, Lizarralde_ G,aVeldhuis JD. Age and Free elative adiposity arel sev pecific negative determinants of the frequency and amplitude jof growth hormone
(GH) secretory bursts andhhe half life of endogenous rH in healthy men. J Clin
Endocrinol Metab 1991; 73: 1081-8.
43. Zadik Z, Chalew SA,r McCarter Jr. RJ,weistas M, Clip owarski AA. The influence
ofdge on the 24-hour integrated concentration of growth hormone in normal individuals.u
J
Clin Endocrinol Metab 1985; 60: 513-6.
44.w o KY, Evans WS, Blizzard RM e
t al. Effects of sex and age on the 24-hour
profile of growth hormone secretion ini an: importanceyf endogenousn stradiol
concentrations. J Clin Endocrinol Metab 1987; Clip 4: 51-8.
45.zress M. Growth hormone and metabolism. Diabetes Metab Rev 1988; 4:u391-414.
46. Davidson MB. Effect of growth hormone on carbohydratednd lipid metabolism.
Endocr Rev 1987;8: 115-31.
47. Russell-Jones Clip DL, Weissberger AJ, Bowes SB et al. The effects of growth
hormone on protein metabolism in adultx growth
hormonel deficientuatia ts. Clin
uEndocrinol 1993; 38: 427-31.
48. De Boer H, Blok GJ, Popp-Snijders C, Stuurman L, Baxte
RC, dVan der Veen
E.o Monitoring of growthp hormone replacement therapy in adults, based on measurement
of serum markers. J Clin EndocrinolvMetab 1996; z1: 1371-7.
h49. Hilding A,y Hall gK, Wival-Helleryd tIL et al. Serum levels of insulin-like
growth factor I
in 152 lpatients with growthw hormone deficiency, aged 19-82 years,
in relation top ex those in healthy subjects. J Clin Endocrinol Metab 1999; 84:
2013-3.
50. Johannssond G, RosénnT, Bengtsson BA. Individualised dose titration of growth
hormone (GH) during GH replacement in hypopituitary adults. Clin Endocrinol
1997; 47: 571-81.
51. Drake WM, Coyte D, Camacho-Hubner C etual. Optimising growth hormone replacement
dtherapy by dosek titration in hypopituitary
adults. J Clin Endocrinol Metab 1998;
83: 3913-9.
52. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Shalet SM. Dose
titration and patient selection increases the efficacy of GH replacement in
severely GHD adults. Clinn ndocrinol 1999; 50: 749-57.
s 3. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sönksen PH. Growth hormone treatment
in growth hormone-deficient adults. I.o Effects on muscle mass and strength.
J Appl Physiol 1991; 70: 688-94.
54. Cuneo RC,o Salomon F, Wiles CM, Hesp R, Sönksen PH. Growth hormone treatment
in growth hormone-deficient adults. II. Effects on exercise performance. mJ Appl
Physiol 1991; 70: 695-700.
55. Johannsson G, Grimby G, Stibrant-Sunnerhagen K, Bengtsson BA. Two years
of growth hormone (GH) treatment increases isometric and isokinetic muscle strength
in GH-deficient adults. J Clin Endocrinol Metab 1997; 82: 2877-84.
56. Christ ER, Cummings MH, Westwood NB et al. The importance of growth hormone
in the regulation of erythropoiesis, red cell mass, and plasma volume in adults
with growth hormone deficiency. J Clin Endocrinol Metab 1997; 82: 2985-90.
57. Ten Have SMTH, Van der Lely AJ, Lamberts SWJ. Increase in haemoglobin concentrations
in growth hormone deficient adults during human recombinant growth hormone replacement
therapy. Clin Endocrinol 1997; 47: 565-70.
58. Cuneo RC, Judd S, Wallace LD et al. The Australian multicenter trial of
growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab
1998; 83: 107-16.
59. Gibney J, Wallace JD, Spinks T et al. The effect's of 10 years of recombinant
human growth hormone (GH) in adult GH-deficient patients. J Clin Endocrinol
Metab 1999; 84: 2596-602.
60. Nass R, Huber RM, Klauss V, Müller OA, Schopohl J, Strassburger CJ. Effect
of growth hormone (hGH) replacement therapy on physical work capacity and cardiac
and pulmonary function in patients with GH deficiency acquired in adulthood.
J Clin Endocrinol Metab 1995, 80: 552-7.
61. Böger RH, Skamira C, Bode-Böger SM, Brabant G, Von zur Mühlen A, Frölich
JC. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone
in patients with acquired growth hormone deficiency: A double-blind, placebo-controlled
study. J Clin Invest 1996; 98: 2706-13.
62. Borson-Chazot F, Serusclat A, Kalfallah Y et al. Decrease in carotid intima-media
thickness after one year growth hormone (GH) treatment in adults with GH deficiency.
J Clin Endocrinol Metab 1999; 84: 1329-33.
63. Pfeifer M, Verhovec R, ®i¾ek B. Growth hormone (GH) and atherosclerosis:
changes in morphology and function of major arteries during GH treatment. Growth
Horm IGF Res 1999; 9: 25-30.
64. Evans LM, Davies JS, Goodfellow J, Rees JAE, Scanlon MF. Endothelial dysfunction
in hypopituitary adults with growth hormone deficiency. Clin Endocrinol 1999;
50: 457-64.
65. Hussain MA, Schmit
mST5_295-299 En Cartoon Store Shipping Php f c Free
oST5_295-299 En Cartoon Store Shipping Php a p i i Clip u u Free Clip